Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | S100A4 | P26447 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24608664 | 0.89 | KMT2A (0.37) | MEN1KMT2AMAPTLMNAPGR | |
| SCHEMBL24894040 | 0.86 | AKT1 (0.38) | MEN1KMT2AKDM4EMAPTLMNA | |
| SCHEMBL24527786 | 0.86 | P2RX4 (0.34) | MEN1KMT2AKDM4EMAPTLMNA | |
| SCHEMBL20938312 | 0.86 | MAOA (0.34) | MEN1KMT2AKDM4EMAPTLMNA | |
| SCHEMBL20938317 | 0.86 | MAOA (0.34) | MEN1KMT2AKDM4EMAPTLMNA | |
| SCHEMBL20315956 | 0.85 | KMT2A (0.42) | MEN1KMT2AKDM4EMAPTLMNA | |
| SCHEMBL15960559 | 0.85 | ESR1 (0.38) | MEN1KMT2AKDM4EMAPTLMNA | |
| SCHEMBL20938462 | 0.84 | ALDH1A1 (0.34) | KMT2APDK2 | |
| SCHEMBL20383140 | 0.84 | MGLL (0.46) | MAPTTHRBTDP1MAPK1 | |
| SCHEMBL17084399 | 0.84 | SMN1; SMN2 (0.37) | MEN1KMT2AKDM4EMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10886476-B2 | Polycyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-01-05 | — | — | US | disclosed |
| US-20190123287-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD (KR) | 2019-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10886476-B2 | Polycyclic compound and organic electroluminescence device including the same | TRPC1, PPOX, TRPC6 | MEN1 1038/4885KMT2A 1464/4885KDM4E 2552/4885 |
| US-20190123287-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | TRPC1, PPOX, TRPC6 | MEN1 1038/4885KMT2A 1464/4885KDM4E 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.